Urology FDA approvals of 2016 February 13, 2017 By Urology Times Staff Urology-related FDA approvals from 2016 encompassed drugs and devices for prostate cancer, renal cell carcinoma, bladder cancer, stone disease, and more. New Products: Two-in-one wire device combines access, safety guides February 10, 2017 By Ben Schwartz Other products discussed include an updated prostate tissue ablation device, a contrast agent for voiding ultrasonography, a bladder cancer test and more. Uro Pipeline: FDA accepts biologics license application for bladder Ca agent January 13, 2017 By Ben Schwartz Other pipeline developments discussed include an implantable device for OAB treatment, a subcutaneous hypogonadism treatment, efficacy results for an HPV drug, and the status of a device-based BPH treatment. New Products: Hybrid basket, grabber provides capture, release of multiple stone sizes December 09, 2016 By Ben Schwartz Other products discussed include a stent system for treating ureteral obstructions, a male infertility test, and more. Uro Pipeline: Data from mUC combination therapy suggests efficacy, safety December 01, 2016 By Ben Schwartz Other pipeline developments discussed include a bladder cancer test, a male infertility assay, and the first oral dosage treatment for hypogonadism. New Products: Test launched to improve prostate biopsy decision process November 11, 2016 By Ben Schwartz Other new products discussed in this article include a surgical training model, devices designed to improve prostate biopsy accuracy, an updated label and more. Uro Pipeline: FDA committee votes in favor of nocturia treatment approval November 01, 2016 By Ben Schwartz Other pipeline developments discussed in this article include the initiation of an intravesical bladder cancer study, a gel treatment for ED that has met its primary endpoint, a patent awarded for the first rechargeable implantable SNM along with some other advancements. New Products: Neuromodulation system for OAB targets tibial nerve July 15, 2016 By Ben Schwartz Other products discussed in this roundup include a plasma vaporization device, a laser fiber safety device, and more. New Products: Single-use ureteroscope, new FDA Approvals for RCC treatment, and an App that helps IC, chronic prostatitis patients January 26, 2016 By Annamarie Iannetta Check out the latest new products. From Single-use ureteroscope addresses shortcomings of reusable scopes, to an App that helps IC, chronic prostatitis patients choose the right foods and much more. Uro Pipeline: 1st patients treated in phase III study of investigational BPH Tx January 01, 2016 By Benjamin P. Saylor Other pipeline products discussed in this article include an immunotherapy for metastatic bladder cancer, a treatment for lower urinary tract symptoms of BPH, and an investigational clear cell renal cell carcinoma treatment.